Is Urinary Beta-2 Microglobulin a Good Predictive Marker in Children With Pyelonephritis?

Author(s):
Behnam SoboutiBehnam Sobouti1,*, Yaser GhavamiYaser Ghavami2
1Ali- Asghar Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
2Burn Research Center, Tehran University of Medical Sciences, Tehran, IR Iran

Archives of Pediatric Infectious Diseases:Vol. 1, issue 2; 105-106
Published online:Jul 15, 2013
Article type:Letter
Received:Jan 01, 2013
Accepted:Jan 07, 2013
How to Cite:Sobouti B, Ghavami Y. Is Urinary Beta-2 Microglobulin a Good Predictive Marker in Children With Pyelonephritis?. Arch Pediatr Infect Dis. 2013;1(2):105-106. doi: https://doi.org/10.5812/pedinfect.10074

Dear Editor,
Regarding recently published article on urinary beta-2 microglobulin (ß2MG) as a prognostic marker in children with pyelonephritis, some issues should be considered (1). ß2MG is a small globular peptide with a molecular weight of 11800 Dalton which can be found on the surface of many cells. It consists of 100 amino acids with a disulfide-linked loop between amino acid 25 and 81; and its tertiary structure is homologous to the CH3- IgG domain. ß2MG passes freely through the glomerular membrane. Thereafter it is reabsorbed to an amount of maximum 99.9% by the proximal tubules (2). In aforementioned interesting article, the relation between urinary ß2M to Creatinine ratio and its effect on kidney damage may not be an incidental finding. Although it is possible to apply ß2M as a prognostic factor in patients with pyelonephritis, but exclusion criteria for patients should be extended more than mentioned. Other contributing factors in increased ß2M are infections (such as CMV and HIV), malignancies (i.e. multiple myeloma), exposure to heavy metals (Mercury, Cadmium), kidney transplant, amyloidosis and drugs (such as Lithium, Cyclosporine, Cisplatin, Aminoglycosides). These issues should be taken into account and are considered in the exclusion criteria (3-6).

Footnotes

References

  • 1.
    Sharifian M, Karimi A, Mohkam M, Dalirani R, Esfandiar N, Tabatabaei SR, et al. Urinary Beta 2-Microglobulin as a Prognostic marker in children with pyelonephritis. Arch Pediatr Infect Dis. 2012;1(1):18-22. https://doi.org/10.5812/pedinfect.4902.
  • 2.
    Lehmann CA. Saunders manual of clinical laboratory science. WB Saunders Company; 1998.
  • 3.
    Del Palacio M, Romero S, Casado JL. Proximal tubular renal dysfunction or damage in HIV-infected patients. AIDS Rev. 2012;14(3):179-87. [PubMed ID: 22833061].
  • 4.
    Heegaard NH. Beta(2)-microglobulin: from physiology to amyloidosis. Amyloid. 2009;16(3):151-73. [PubMed ID: 19657763]. https://doi.org/10.1080/13506120903151775.
  • 5.
    Liabeuf S, Lenglet A, Desjardins L, Neirynck N, Glorieux G, Lemke HD, et al. Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients. Kidney Int. 2012;82(12):1297-303. [PubMed ID: 22895515]. https://doi.org/10.1038/ki.2012.301.
  • 6.
    Yang J, Qian J, Wezeman M, Wang S, Lin P, Wang M, et al. Targeting beta2-microglobulin for induction of tumor apoptosis in human hematological malignancies. Cancer Cell. 2006;10(4):295-307. [PubMed ID: 17045207]. https://doi.org/10.1016/j.ccr.2006.08.025.

Similar Articles

2
Apr
2013

Urinary Beta 2-Microglobulin as a Prognostic marker in children with pyelonephritis Running title: Beta 2-Microglobulin a Prognostic marker

Mostafa Sharifian,
Abdollah Karimi,
Masoumeh Mohkam,
Reza Dalirani,
Sedigheh Rafiei Tabatabaei,
Mahmood Nourisafa

Sharifian M, Karimi A, Mohkam M, Dalirani R, Tabatabaei S, et al. Urinary Beta 2-Microglobulin as a Prognostic marker in children with pyelonephritis Running title: Beta 2-Microglobulin a Prognostic marker. Arch Pediatr Infect Dis. 2013;1(1):. doi: https://doi.org/10.5812/pedinfect.4902

7
Dec
2014

Association Between Plasma Beta-2 Microglobulin Level and Cardiac Performance in Patients With Chronic Kidney Disease

Omid Sedighi,
Saeid Abediankenari,
Batoul Omranifar

Sedighi O, Abediankenari S, Omranifar B. Association Between Plasma Beta-2 Microglobulin Level and Cardiac Performance in Patients With Chronic Kidney Disease. Nephro-Urol Mon. 2015;7(1):e23563. doi: https://doi.org/10.5812/numonthly.23563

1
Apr
2012

Effect of Inflammatory Factors on ?2-Microglobulin in Hemodialysis Patients

Maryam Rahbar,
Baharak Mehdipour-Aghabagher

Rahbar M, Mehdipour-Aghabagher B. Effect of Inflammatory Factors on ?2-Microglobulin in Hemodialysis Patients. Shiraz E-Med J. 2012;13(2):. doi:

30
Jun
2013

Urine β 2-Microglobolin in the Patients with Congenital Heart Disease

Noor Mohammad Noori,
Simin Sadeghi,
Iraj Shahramian,
Kambiz Keshavarz

Noori NM, Sadeghi S, Shahramian I, Keshavarz K. Urine β 2-Microglobolin in the Patients with Congenital Heart Disease. Int Cardiovasc Res J. 2017;7(2):e12705. doi:

31
Dec
2012

A Study on the Relationship between Serum Beta 2-Microglobulin Levels, Underlying Chronic Kidney Disease, and Peripheral Arterial Disease in High-Vascular-Risk Patients

Diego Real de Asúa,
Ramón Puchades,
Iluminada García-Polo,
Carmen Suárez

Real de Asúa D, Puchades R, García-Polo I, Suárez C. A Study on the Relationship between Serum Beta 2-Microglobulin Levels, Underlying Chronic Kidney Disease, and Peripheral Arterial Disease in High-Vascular-Risk Patients. Int Cardiovasc Res J. 2017;6(4):e12784. doi:


Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC